Synergistic effects of COMT and TPH2 on social cognition

Psychiatry (New York)

Volumn 76, Issue 3, 2013, Pages 273-294

  Lin, Chieh Hsin ^a,b   Tseng, Yu Lun ^a,c   Huang, Chieh Liang ^a   Chang, Yue Cune ^d   Tsai, Guochuan E ^e   Lane, Hsien Yuan ^a,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAMKANG UNIVERSITY   (Taiwan)

^e HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; SEROTONIN; TPH2 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

ADOLESCENT; ADULT; AGED; ALLELE; ANALYSIS OF VARIANCE; BIOLOGICAL MODEL; CHINA; EMOTION; EMOTIONAL INTELLIGENCE; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPING TECHNIQUE; HOMOZYGOTE; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PERCEPTION; PERSONALITY ASSESSMENT; PHYSIOLOGY; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT; ARTICLE; METHODOLOGY; PERSONALITY TEST; STATISTICS;

ADOLESCENT; ADULT; AGED; ALLELES; ANALYSIS OF VARIANCE; CATECHOL O-METHYLTRANSFERASE; CHINA; DOPAMINE; EMOTIONAL INTELLIGENCE; EMOTIONS; FEMALE; GENE EXPRESSION REGULATION; GENOTYPING TECHNIQUES; HOMOZYGOTE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, GENETIC; NEUROPSYCHOLOGICAL TESTS; PERSONALITY ASSESSMENT; POLYMORPHISM, GENETIC; SEROTONIN; SOCIAL PERCEPTION; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 84890053224     PISSN: 00332747     EISSN: 1943281X     Source Type: Journal    
DOI: 10.1521/psyc.2013.76.3.273     Document Type: Article

References (99)

1. Adolphs, R. (2001). The neurobiology of social cognition. Current Opinion in Neurobiology, 11, 231–239.
2. American Psychiatric Association. (1994). Structured Clinical Interview for DSM-IV. Washington, DC: American Psychiatric Press.
3. Arias, B., Serretti, A., Lorenzi, C., Gasto, C., Catalan, R., Fananas, L., & Ba, M. B. (2006). Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. Journal of Affective Disorders, 90, 251–256.
4. Bae, S. M., Lee, S. H., Park, Y. M., Hyun, M. H., & Yoon, H. (2010). Predictive factors of social functioning in patients with schizophrenia: Exploration for the best combination of variables using data mining. Psychiatry Investigation, 7, 93–101.
5. Balanza-Martinez, V., Rubio, C., Selva-Vera, G., Martinez-Aran, A., Sanchez-Moreno, J., Salazar-Fraile, J., et al. (2008). Neurocognitive endophe-notypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: A systematic review. Neuroscience and Biobehavioral Reviews, 32, 1426–1438.
6. Barnett, J. H., Jones, P. B., Robbins, T. W., & Muller, U. (2007). Effects of the catechol-O-meth-yltransferase Val158Met polymorphism on executive function: A meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Molecular Psychiatry, 12, 502–509.
7. Beer, J. S., & Ochsner, K. N. (2006). Social cognition: A multi-level analysis. Brain Research, 1079, 98–105.
8. Bell, M., Tsang, H. W., Greig, T. C., & Bryson, J. (2009). Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophrenia Bulletin, 35, 738–747.
9. Bishop, S. J., Cohen, J. D., Fossella, J., Casey, B. J., & Farah, M. J. (2006). COMT genotype influences prefrontal response to emotional distraction. Cognitive, Affective & Behavioral Neuroscience, 6, 62–70.
10. Brown, S. M., Peet, E., Manuck, S. B., Williamson, D. E., Dahl, R. E., Ferrell, R. E., et al. (2005). A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Molecular Psychiatry, 10, 805, 884–888.
11. Canli, T., Congdon, E., Gutknecht, L., Constable, R. T., & Lesch, K. P. (2005). Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. Journal of Neural Transmission, 112, 1479–1485.
12. Carr, S. E. (2009). Emotional intelligence in medical students: Does it correlate with selection measures? Medical Education, 43, 1069–1077.
13. Charlton, R. A., Barrick, T. R., Markus, H. S., & Morris, R. G. (2009). Theory of mind associations with other cognitive functions and brain imaging in normal aging. Psychology and Aging, 24, 338–348.
14. Chen, C. Y., Lu, R. B., Yeh, Y. W., Shih, M. C., & Huang, S. Y. (2011). Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes, Brain, and Behavior, 10, 316–324.
15. Chen, G. L., Vallender, E. J., & Miller, G. M. (2008). Functional characterization of the human TPH2 5’ regulatory region: Untranslated region and polymorphisms modulate gene expression in vitro. Human Genetics, 122, 645–657.
16. Couture, S. M., Granholm, E. L., & Fish, S. C. (2011). A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia. Schizophrenia Research, 125, 152–160.
17. Couture, S. M., Penn, D. L., & Roberts, D. L. (2006). The functional significance of social cognition in schizophrenia: A review. Schizophrenia Bulletin, 32, S44-63.
18. Cuesta, M. J., Peralta, V., & Zarzuela, A. (1998). Illness duration and neuropsychological impairments in schizophrenia. Schizophrenia Research, 33, 141–150.
19. Depp, C. A., Moore, D. J., Sitzer, D., Palmer, B. W., Eyler, L. T., Roesch, S., et al. (2007). Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects. Journal of Affective Disorders, 101, 201–209.
20. Drabant, E. M., Hariri, A. R., Meyer-Lindenberg, A., Munoz, K. E., Mattay, V. S., Kolachana, B. S., et al. (2006). Catechol O-methyltransferase val-158 met genotype and neural mechanisms related to affective arousal and regulation. Archives of General Psychiatry, 63, 1396–1406.
21. Eack, S. M., Greeno, C. G., Pogue-Geile, M. F., Newhill, C. E., Hogarty, G. E., & Keshavan, M. S. (2010). Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophrenia Bulletin, 36, 370–380.
22. Eack, S. M., Mermon, D. E., Montrose, D. M., Miewald, J., Gur, R. E., Gur, R. C., et al. (2010). Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophrenia Bullettn, 36, 1081–1088.
23. Enter, D., Colzato, L. S., & Roelofs, K. (2012). Dopamine transporter polymorphisms affect social approach-avoidance tendencies. Genes, Brain and Behavior, 6, 671–676.
24. Extremera, N., Fernandez-Berrocal, P., & Salovey, P. (2006). Spanish version of the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT). Version 2.0: Reliabilities, age and gender differences. Psicothema, 18, 42–48.
25. Ferre, S., Cortes, R., & Artigas, F. (1994). Dopaminergic regulation of the serotonergic raphe-striatal pathway: Microdialysis studies in freely moving rats. Journal of Neuroscience, 14, 4839–4846.
26. Fett, A. K., Viechtbauer, W., Dominguez, M. D., Penn, D. L., van Os, J., & Krabbendam, L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience and Biobehavioral Reviews, 35, 573–588.
27. Fiszdon, J. M., & Johannesen, J. K. (2010). Functional significance of preserved affect recognition in schizophrenia. Psychiatry Research, 176, 120–125.
28. Garcia-Garcia, M., Clemente, I., Dominguez-Borras, J., & Escera, C. (2010). Dopamine transporter regulates the enhancement of novelty processing by a negative emotional context. Neuropsychologia, 48, 1483–1488.
29. Gard, D. E., Fisher, M., Garrett, C., Genevsky, A., & Vinogradov, S. (2009). Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia. Schizophrenia Research, 115, 74–81.
30. Goldberg, T. E., Egan, M. F., Gscheidle, T., Coppola, R., Weickert, T., Kolachana, B. S., et al. (2003). Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Archives of General Psychiatry, 60, 889–896.
31. Gong, P., Zheng, A., Zhang, K., Lei, X., Li, F., Chen, D., et al. (2010). Association analysis between 12 genetic variants of ten genes and personality traits in a young Chinese Han population. Journal of Molecular Neuroscience, 42, 120–126.
32. Gonzalez-Burgos, I., & Feria-Velasco, A. (2008). Serotonin/dopamine interaction in memory formation. Progress in Brain Research, 172, 603–623.
33. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321–330.
34. Green, M. F., Bearden, C. E., Cannon, T. D., Fiske, A. P., Hellemann, G. S., Horan, W. P., et al. Social cognition in schizophrenia. Part 1: Performance across phase of illness. Schizophrenia Bulletin, 38, 852–864.
35. Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”? Schizophrenia Bulletin, 26, 119–136.
36. Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., et al. (2004). Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MAT-RICS conference to select cognitive domains and test criteria. Biological Psychiatry, 56, 301–307.
37. Green, M. F., Olivier, B., Crawley, J. N., Penn, L., & Silverstein, S. (2005). Social cognition in schizophrenia: Recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophrenia Bulletin, 31, 882–887.
38. Guan, X. M., & McBride, W. J. (1989). Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Research Bulletin, 23, 541–547.
39. Hariri, A. R., Drabant, E. M., Munoz, K. E., Kolachana, B. S., Mattay, V. S., Egan, M. F., & Weinberger, D. R. (2005). A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry, 62, 146–152.
40. Harvey, P. D., Reichenberg, A., Bowie, C. R., Patterson, T. L., & Heaton, R. K. (2010). The course of neuropsychological performance and functional capacity in older patients with schizophrenia: Influences of previous history of long-term institutional stay. Biological Psychiatry, 67, 933–939.
41. Horan, W. P., Green, M. F., Degroot, M., Fiske, A., Hellemann, G., Kee, K., et al. (2012). Social cognition in schizophrenia. Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin, 38, 865–872.
42. Hosak, L. (2007). Role of the COMT gene Val-158Met polymorphism in mental disorders: A review. European Psychiatry, 22, 276–281.
43. Inoue, H., Yamasue, H., Tochigi, M., Takei, K., Suga, M., Abe, O., et al. (2010). Effect of tryptophan hydroxylase-2 gene variants on amygdalar and hippocampal volumes. Brain Research, 1331, 51–57.
44. Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., et al. The MATRICS Consensus Cognitive Battery. Part 2: Co-norming and standardization. American Journal of Psychiatry, 165, 214–220.
45. Kim, Y. K., Lee, H. J., Yang, J. C., Hwang, J. A., & Yoon, H. K. (2009). A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behavior Genetics, 39, 170–175.
46. Kunda, Z. (1999). Social cognition: Making sense of people. Cambridge, MA: MIT Press.
47. Langley, K., Heron, J., O’Donovan, M. C., Owen, M. J., & Thapar, A. (2010). Genotype link with extreme antisocial behavior: The contribution of cognitive pathways. Archives of General Psychiatry, 67, 1317–1323.
48. Laroi, F., Fonteneau, B., Mourad, H., & Raballo, A. (2010). Basic emotion recognition and psychopathology in schizophrenia. Journal of Nervous and Mental Disease, 198, 79–81.
49. Lemogne, C., Gorwood, P., Boni, C., Pessiglione, M., Lehericy, S., & Fossati, P. (2011). Cognitive appraisal and life stress moderate the effects of the 5-HTTLPR polymorphism on amygdala reactivity. Human Brain Mapping, 32, 1856–1867.
50. Lin, Y. M., Chao, S. C., Chen, T. M., Lai, T. J., Chen, J. S., & Sun, H. S. (2007). Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese. Archives of General Psychiatry, 64, 1015–1024.
51. Lo, C. H., Tsai, G. E., Liao, C. H., Wang, M. Y., Chang, J. P., Tsuang, H. C., et al. (2010). Emotional management and 5-HT2A receptor gene variance in patients with schizophrenia. Biological Psychology, 83, 79–83.
52. Lowry, C. A., Hale, M. W., Evans, A. K., Heerkens, J., Staub, D. R., Gasser, P. J., et al. (2008). Serotonergic systems, anxiety, and affective disorder: Focus on the dorsomedial part of the dorsal raphe nucleus. Annals of the New York Academy of Sciences, 1148, 86–94.
53. Ma, W. F., Tsai, G. E., Chang, J. P., & Lane, H. Y. (2010). Reliability and validity of three Chineseversion tasks of Mayer-Salovey-Caruso Emotional Intelligence Test. Journal of Clinical Nursing, 19, 2656–2658.
54. Mandelli, L., Serretti, A., Marino, E., Pirovano, A., Calati, R., & Colombo, C. (2007). Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. International Journal of Neuropsychopharmacology, 10, 437–447.
55. Martin-Ruiz, R., Ugedo, L., Honrubia, M. A., Mengod, G., & Artigas, F. (2001). Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. Journal of Neurochemistry, 77, 762–775.
56. Mayer, J. D., & Salovey, P. (1997). What is emotional intelligence? In P. Salovey and D. Sluyter (Eds.), Emotional development and emotional intelligence: Educational implications (pp. 3–31). New York: Basic Books.
57. Mayer, J. D., Salovey, P. S., & Caruso, D. R. Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) user’s manual. Toronto, Ontario: MHS.
58. Mayer, J. D., Salovey, P., Caruso, D. R., & Sitarenios, G. (2003). Measuring emotional intelligence with the MSCEIT V2.0. Emotion, 3, 97–105.
59. Meltzer, H., & Massey, B. (2011). The role of serotonin receptors in the action of atypical antipsychotic drugs. Current Opinion in Pharmacology, 11, 59–67.
60. Mendlin, A., Martin, F. J., & Jacobs, B. L. (1998). Involvement of dopamine D2 receptors in apomorphine-induced facilitation of forebrain serotonin output. European Journal of Pharmacology, 351, 291–298.
61. Mier, D., Kirsch, P., & Meyer-Lindenberg, A. (2010). Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis. Molecular Psychiatry, 15, 918–927.
62. Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 12–15.
63. Nakamura, K., Sekine, Y., Ouchi, Y., Tsujii, M., Yoshikawa, E., Futatsubashi, M., et al. (2010). Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Archives of General Psychiatry, 67, 59–68.
64. Napolitano, A., Cesura, A. M., & Da Prada, M. (1995). The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. Journal of Neural Transmission, 45, 35–45.
65. Olvera-Cortes, M. E., Anguiano-Rodriguez, P., Lopez-Vazquez, M. A., & Alfaro, J. M. (2008). Serotonin/dopamine interaction in learning. Progress in Brain Research, 172, 567–602.
66. Osinsky, R., Schmitz, A., Alexander, N., Kuepper, Y., Kozyra, E., & Hennig, J. (2009). TPH2 gene variation and conflict processing in a cognitive and an emotional Stroop task. Behavioural Brain Research, 198, 404–410.
67. Pan, Y. J., Chen, S. H., Chen, W. J., & Liu, S. K. Affect recognition as an independent social function determinant in schizophrenia. Comprehensive Psychiatry, 50, 443–452.
68. Penn, D. L., Corrigan, P. W., Bentall, R. P., Racenstein, J. M., & Newman, L. (1997a). Social cognition in schizophrenia. Psychological Bulletin, 121, 114–132.
69. Penn, D. L., Spaulding, W., Reed, D., Sullivan, M., Mueser, K. T., & Hope, D. A. (1997b). Cognition and social functioning in schizophrenia. Psychiatry, 60, 281–291.
70. Penn, D. L., Keefe, R. S., Davis, S. M., Meyer, P. S., Perkins, D. O., Losardo, D., et al. (2009). The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. Schizophrenia Research, 115, 17–23.
71. Pinkham, A. E., Hopfinger, J. B., Pelphrey, K. A., Piven, J., & Penn, D. L. (2008). Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophrenia Research, 99, 164–175.
72. Premkumar, P., Cooke, M. A., Fannon, D., Peters, Michel, T. M., Aasen, I., et al. (2008). Misattribution bias of threat-related facial expressions is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. European Psychiatry, 23, 14–19.
73. Reitan, R. M. (1958). Validity of the Trail Making Test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271–276.
74. Scourfield, J., McGuffin, P., & Thapar, A. (1997). Genes and social skills. Bioessays, 19, 1125–1127.
75. Sergi, M. J., Green, M. F., Widmark, C., Reist, C., Erhart, S., Braff, D. L., et al. (2007). Social cognition [corrected] and neurocognition: Effects of risperidone, olanzapine, and haloperidol. American Journal of Psychiatry, 164, 1585–1592.
76. Shayegan, D. K., & Stahl, S. M. (2005). Emotion processing, the amygdala, and outcome in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 840–845.
77. Silver, H., Feldman, P., Bilker, W., & Gur, R. C. Working memory deficit as a core neuropsychological dysfunction in schizophrenia. American Journal of Psychiatry, 160, 1809–1816.
78. Skuse, D. (2003). X-linked genes and the neural basis of social cognition. Novartis Foundation Symposium, 251, 84–98; discussion, 98–108; 109–111, 281–297.
79. Skuse, D. H., & Gallagher, L. (2011). Genetic influences on social cognition. Pediatric Research, 69, 85R-91R.
80. Smolka, M. N., Schumann, G., Wrase, J., Grusser, S. M., Flor, H., Mann, K., et al. (2005). Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Journal of Neuroscience, 25, 836–842.
81. Sternberg, S. (1966). High-speed scanning in human memory. Science, 153, 652–654.
82. Stoltenberg, S. F., Glass, J. M., Chermack, S. T., Flynn, H. A., Li, S., Weston, M. E., et al. (2006). Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene. Psychiatric Genetics, 16, 35–38.
83. Swart, M., Bruggeman, R., Laroi, F., Alizadeh, B. Z., Kema, I., Kortekaas, R., et al. (2011). COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems. NeuroImage, 55, 338–344.
84. Szily, E., Bowen, J., Unoka, Z., Simon, L., & Keri, S. (2008). Emotion appraisal is modulated by the genetic polymorphism of the serotonin transporter. Journal of Neural Transmission, 115, 819–822.
85. Tsuang, H. C., Lin, S. H., Liu, S. K., Hsieh, M., Hwang, T. J., Liu, C. M., et al. (2006). More severe sustained attention deficits in nonpsychotic siblings of multiplex schizophrenia families than in those of simplex ones. Schizophrenia Research, 87, 172–180.
86. van Hooren, S., Versmissen, D., Janssen, I., Myin-Germeys, I., a Campo, J., Mengelers, R., et al. (2008). Social cognition and neurocognition as independent domains in psychosis. Schizophrenia Research, 103, 257–265.
87. Waider, J., Araragi, N., Gutknecht, L., & Lesch, K. P. (2011). Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: A perspective. Psychoneuroendocrinology, 36, 393–405.
88. Walter, H., Schnell, K., Erk, S., Arnold, C., Kirsch, P., Esslinger, C., et al. (2011). Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Molecular Psychiatry, 16, 462–470.
89. Wechsler, D. (1991). Wechsler Intelligence Scale for Children, 3rd ed. San Antonio, TX: Psychological Association.
90. Wechsler, D. (1997). Wechsler Adult Intelligence Scale, 3rd ed. San Antonio, TX: Psychological Association.
91. Wechsler, D. (1997). Wechsler Memory Scale, 3rd ed. San Antonio, TX: Psychological Association.
92. Wilson, C. R., Gaffan, D., Browning, P. G., & Baxter, M. G. (2010). Functional localization within the prefrontal cortex: Missing the forest for the trees? Trends in Neurosciences, 33, 533–540.
93. Wishart, H. A., Roth, R. M., Saykin, A. J., Rhodes, C. H., Tsongalis, G. J., Pattin, K. A., et al. (2011). COMT Val158Met genotype and individual differences in executive function in healthy adults. Journal of the International Neuropsychological Society, 17, 174–180.
94. Wolf, F., Brune, M., & Assion, H. J. (2010). Theory of mind and neurocognitive functioning in patients with bipolar disorder. Bipolar Disorders, 12, 657–666.
95. Ye, S., Dhillon, S., Ke, X., Collins, A. R., & Day, N. (2001). An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research, 29, E88-8.
96. Young, H. F., & Bentall, R. P. (1995). Hypothesis testing in patients with persecutory delusions: Comparison with depressed and normal subjects. British Journal of Clinical Psychology, 34, 353–369.
97. Zhang, C., Li, Z., Shao, Y., Xie, B., Du, Y., Fang, Y., et al. (2011). Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in a Chinese Han population. Journal of Molecular Neuroscience, 43, 406–411.
98. Zhang, X., Gainetdinov, R. R., Beaulieu, J. M., Sotnikova, T. D., Burch, L. H., Williams, R. B., et al. (2005). Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron, 45, 11–16.
99. Zhang, X., Beaulieu, J. M., Gainetdinov, R. R., & Caron, M. G. (2006). Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cellular and Molecular Life Sciences, 63, 6–11.